-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Edwards Lifesciences, Raises Price Target to $96

Benzinga·12/05/2025 16:15:09
語音播報
Wells Fargo analyst Larry Biegelsen maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $95 to $96.